Vivos Therapeutics, Inc. (VVOS)
NASDAQ
Vivos Therapeutics, Inc. Gross Profit 2019–2025
Vivos Therapeutics, Inc. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Vivos Therapeutics, Inc. gross profit for the quarter ending March 31, 2026 was 3.1 M, a 102.72% increase year-over-year.
- Vivos Therapeutics, Inc. gross profit for the twelve months ending March 31, 2026 was 10.6 M, a 22.45% increase year-over-year.
- Vivos Therapeutics, Inc. annual gross profit for 2025 was 10.5 M, a 16.89% increase from 2024.
- Vivos Therapeutics, Inc. annual gross profit for 2024 was 9.0 M, a 9.04% increase from 2023.
- Vivos Therapeutics, Inc. annual gross profit for 2023 was 8.3 M, a 17.45% decrease from 2022.
- Vivos Therapeutics, Inc. annual gross profit for 2022 was 10.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vivos Therapeutics, Inc. Gross Profit — FAQ
Vivos Therapeutics, Inc. (VVOS) gross profit over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Vivos Therapeutics, Inc.'s gross profit?
Vivos Therapeutics, Inc. (VVOS) reported gross profit of $11M for fiscal 2025.
Where can I see VVOS's gross profit history?
The chart and table above show Vivos Therapeutics, Inc.'s gross profit by year and by quarter, including the growth rate.